Anika Therapeutics reported $26.35M in Current Liabilities for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Agenus AGEN:US USD 173.07M 13.35M
Agios Pharmaceuticals AGIO:US USD 53.6M 5.2M
Anika Therapeutics ANIK:US USD 26.35M 3.08M
Arrowhead Research ARWR:US USD 138.85M 10.64M
Clovis Oncology CLVS:US USD 747.87M 626.6M
Enanta Pharmaceuticals ENTA:US USD 29.83M 6.79M
Halozyme Therapeutics HALO:US USD 109.38M 90.13M
Heron Therapeutics HRTX:US USD 93.88M 15.62M
Immunogen IMGN:US USD 103.64M 16.57M
Insmed INSM:US USD 137.65M 23.84M
Intrexon XON:US USD 104.86M 74.96M
Johnson & Johnson JNJ:US USD 45.54B 722M
Karyopharm Therapeutics KPTI:US USD 61.76M 780K
Ligand Pharmaceuticals LGND:US USD 135.24M 32.61M
Macrogenics MGNX:US USD 50.05M 831K
Merit Medical Systems MMSI:US USD 213.04M 17.44M
Peregrine Pharmaceuticals PPHM:US USD 82.38M 10.97M
Rigel Pharmaceuticals RIGL:US USD 47.26M 7.69M
Sangamo Biosciences SGMO:US USD 122.36M 2.37M
Smith & Nephew PLC SN/:LN 2.12B 14M
Stryker SYK:US USD 4.57B 167M
Surmodics SRDX:US USD 32.08M 2.69M
Veracyte VCYT:US USD 58.35M 993K
Xencor XNCR:US USD 90.03M 14.99M
Zimmer Biomet Holdings Inc ZBH:US USD 2.3B 167.9M